Pharmaceutical makers face rough sailing in health insurance price

With the recent decision of the National Health Insurance Corporation to reject the listing of Chong Kun Dang's Prigrel (clopidogrel resignate) into the positive list, analysts say that the future for the formulation-modified new drugs is uncertain.

Only medicines proven effective but also price-competitive will be covered by the health insurance, Hyun Soo-yeop, an official of the Ministry o...